Compound Detail
CHEMBL20734
NEMONAPRIDE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL20734 |
| Name | NEMONAPRIDE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | KRVOJOCLBAAKSJ-UHFFFAOYSA-N |
10
Targets
35
Activities
3
Assay Types
0
PK Parameters
20
Publications
3
Known Names
Molecular Properties
387.9
MW (Da)
3.78
ALogP
4
HBA
2
HBD
53.6
PSA (Ų)
0.79
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Activity Summary
Ki 24 meas. best 9.8
Kd 7 meas. best 11.0
IC50 4 meas. best 9.32
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dopamine receptor D2 and D3 CHEMBL2111342 | Kd | 11.0 | 10.51 | 0.0 | 2 |
| D(2) dopamine receptor CHEMBL339 | Kd | 10.85 | 10.825 | 0.0 | 2 |
| D(3) dopamine receptor CHEMBL3138 | Kd | 10.22 | 10.205 | 0.1 | 2 |
| D(3) dopamine receptor CHEMBL3138 | Ki | 9.8 | 9.8 | 0.2 | 1 |
| D(2) dopamine receptor CHEMBL339 | Ki | 9.8 | 9.8 | 0.2 | 1 |
| D(4) dopamine receptor CHEMBL219 | Kd | 9.68 | 9.68 | 0.2 | 1 |
| Unchecked CHEMBL612545 | Ki | 9.54 | 8.8092 | 0.3 | 12 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 9.32 | 9.32 | 0.5 | 1 |
| D(4) dopamine receptor CHEMBL219 | Ki | 9.12 | 9.04 | 0.8 | 4 |
| D(3) dopamine receptor CHEMBL234 | Ki | 9.07 | 9.0 | 0.9 | 2 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.79 | 8.72 | 1.6 | 3 |
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 8.14 | 8.14 | 7.2 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | IC50 | 7.31 | 7.31 | 49.0 | 1 |
| D(4) dopamine receptor CHEMBL219 | IC50 | 7.01 | 7.01 | 98.2 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 6.27 | 6.27 | 540.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29051383 | 10.1126/science.aan5468 | Unchecked | 13 |
| 6120234 | 10.1021/jm00142a019 | Rattus norvegicus | 4 |
| 29051383 | 10.1126/science.aan5468 | D(4) dopamine receptor | 4 |
| 8809161 | 10.1021/jm960159f | Rattus norvegicus | 4 |
| - | 10.1007/s00044-004-0006-x | D(3) dopamine receptor | 4 |
| - | 10.1007/s00044-004-0006-x | Dopamine receptor D2 and D3 | 4 |
| - | 10.1007/s00044-004-0006-x | D(2) dopamine receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 29051383 | 10.1126/science.aan5468 | D(2) dopamine receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine